![Oral Antiviral Treatments for COVID-19: Time to Revisit? | Center For Global Development | Ideas to Action Oral Antiviral Treatments for COVID-19: Time to Revisit? | Center For Global Development | Ideas to Action](https://www.cgdev.org/sites/default/files/2022-12/covid-antiviral-note-card.jpeg)
Oral Antiviral Treatments for COVID-19: Time to Revisit? | Center For Global Development | Ideas to Action
![078. Insabi inicia entrega de medicamento Paxlovid para tratar a pacientes con COVID grave | Instituto de Salud para el Bienestar | Gobierno | gob.mx 078. Insabi inicia entrega de medicamento Paxlovid para tratar a pacientes con COVID grave | Instituto de Salud para el Bienestar | Gobierno | gob.mx](https://www.gob.mx/cms/uploads/press/main_image/235280/post__com_078_imagen.jpg)
078. Insabi inicia entrega de medicamento Paxlovid para tratar a pacientes con COVID grave | Instituto de Salud para el Bienestar | Gobierno | gob.mx
![Prof. Mario Chiong opina sobre antiviral contra el Coronavirus de Pfizer en diario Las Ultimas Noticias - Universidad de Chile Prof. Mario Chiong opina sobre antiviral contra el Coronavirus de Pfizer en diario Las Ultimas Noticias - Universidad de Chile](https://uchile.cl/dam/jcr:5e5708dd-208a-4472-8aec-5ca96e84328d/DESTACADO-MARIOCHIONG-LUN-161221.png)
Prof. Mario Chiong opina sobre antiviral contra el Coronavirus de Pfizer en diario Las Ultimas Noticias - Universidad de Chile
![A strategy that gives half of the world a discount on COVID-19 antivirals, but keeps a firm grip on power - Speaking of Medicine and Health A strategy that gives half of the world a discount on COVID-19 antivirals, but keeps a firm grip on power - Speaking of Medicine and Health](https://speakingofmedicine.plos.org/wp-content/uploads/sites/14/2022/05/Figure.jpeg)
A strategy that gives half of the world a discount on COVID-19 antivirals, but keeps a firm grip on power - Speaking of Medicine and Health
![People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe](https://www.bostonglobe.com/resizer/TATClwdDgaNNaIYiYzXrtgxY71I=/arc-anglerfish-arc2-prod-bostonglobe/public/DWMH3NIHXOFICJ75UZIYV2RCTI.jpg)
People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe
![James Packard Love on X: "Chile NGO files for compulsory license on Paxlovid patents. @innovarteorg https://t.co/DBMppfqrP7" / X James Packard Love on X: "Chile NGO files for compulsory license on Paxlovid patents. @innovarteorg https://t.co/DBMppfqrP7" / X](https://pbs.twimg.com/media/FIb0zj0X0AU6fgE.png)
James Packard Love on X: "Chile NGO files for compulsory license on Paxlovid patents. @innovarteorg https://t.co/DBMppfqrP7" / X
![Inequality fuels COVID death rates across Latin America: Report | Coronavirus pandemic News | Al Jazeera Inequality fuels COVID death rates across Latin America: Report | Coronavirus pandemic News | Al Jazeera](https://www.aljazeera.com/wp-content/uploads/2022/04/2021-06-07T181225Z_1969132029_RC2SVN9XZW1C_RTRMADP_3_HEALTH-CORONAVIRUS-CHILE.jpg?resize=1800%2C1800)
Inequality fuels COVID death rates across Latin America: Report | Coronavirus pandemic News | Al Jazeera
![White House Focuses Efforts on Increasing Supply of Paxlovid | The Well News | Pragmatic, Governance, Fiscally Responsible, News & Analysis White House Focuses Efforts on Increasing Supply of Paxlovid | The Well News | Pragmatic, Governance, Fiscally Responsible, News & Analysis](https://www.thewellnews.com/wp-content/uploads/2022/04/covid.jpg)
White House Focuses Efforts on Increasing Supply of Paxlovid | The Well News | Pragmatic, Governance, Fiscally Responsible, News & Analysis
![MEDSCAPE SURVEY FINDS REASONS PAXLOVID IS UNDERPRESCRIBED FOR THOSE 65 AND OLDER, DESPITE ITS EFFECTIVENESS AGAINST COVID COMPLICATIONS MEDSCAPE SURVEY FINDS REASONS PAXLOVID IS UNDERPRESCRIBED FOR THOSE 65 AND OLDER, DESPITE ITS EFFECTIVENESS AGAINST COVID COMPLICATIONS](https://mma.prnewswire.com/media/1982577/Medscape_paxlovid_survey.jpg?p=facebook)